+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-viral Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (Chemical, Physical), By Application (Research, Therapeutics), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 6052238
Description Jump to:
The global non-viral gene delivery technologies market size is anticipated to reach USD 7.11 billion by 2030 and grow at a CAGR of 12.29% from 2025 to 2030 during the forecast period. The market's growth is driven by the growing demand for safe, scalable, and cost-effective alternatives to viral vectors in gene therapy and research. Unlike viral methods, non-viral technologies such as lipid nanoparticles (LNPs), polymers, and electroporation offer lower immunogenicity and reduced manufacturing complexities. These attributes make them highly suitable for large-scale applications, including mRNA-based vaccines and CRISPR/Cas9-based gene editing therapies. The success of mRNA COVID-19 vaccines by Moderna and Pfizer-BioNTech further validated the potential of non-viral delivery systems, spurring global investment in this sector.

Advancements in nanotechnology and biomaterials are further accelerating innovation in the field. Nanoparticles, lipoplexes, and hybrid carriers are being optimized for enhanced transfection efficiency and targeted delivery. With the rising prevalence of chronic diseases, including cancer, rare genetic disorders, and cardiovascular conditions, the need for effective and precise therapeutic solutions has surged. Non-viral technologies, with their ability to deliver large genetic payloads and support repeat administrations, are pivotal in addressing these unmet medical needs. In addition, their versatility in both in vitro research applications and in vivo therapeutic use cases expands their adoption across biotechnology, pharmaceutical companies, and academic institutes.

The rising government funding and private investments in gene therapy research are also key drivers of market growth. Regions like North America and Europe lead in terms of R&D, but emerging economies in Asia-Pacific, such as China and India, are rapidly advancing due to increasing biotech infrastructure and supportive regulatory frameworks. Furthermore, partnerships between biotech companies and academic institutions are fostering innovation and expanding the accessibility of non-viral delivery solutions, ensuring their relevance in the rapidly evolving field of gene therapy.

Non-viral Gene Delivery Technologies Market Report Highlights

  • The chemical segment accounted for the largest revenue share in 2024 and is projected to witness the fastest growth rate over the forecast period. The chemical mode of non-viral gene delivery technologies is driven by the increasing demand for efficient, safe, and scalable gene delivery systems.
  • In 2024, research dominated the market with the largest revenue share, driven by the increasing demand for versatile, efficient, and cost-effective tools to investigate gene function, expression, and regulation.
  • By end use, the research and academic institutes segment captured the largest revenue share of 48.11% in 2024 and is expected to experience the fastest CAGR during the forecast period. This growth is fueled by the rising demand for reliable, efficient, and cost-effective approaches to study gene function, expression, and modification.
  • The North American region dominated globally with a market share of 41.25% in 2024. The region benefits from advanced healthcare infrastructure, enabling the rapid adoption of innovative gene delivery techniques. Growing interest in precision medicine and increasing clinical trials focused on genetic disorders further boost market growth. In addition, government initiatives and funding for genomic research contribute to the expanding use of non-viral delivery technologies.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Mode Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Adoption in Therapeutics and Research
3.2.1.2. Technological Advancements and Innovation
3.2.2. Market Restraint Analysis
3.2.2.1. Limited Delivery Efficiency for Complex Targets
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Mode Business Analysis
4.1. Mode Segment Dashboard
4.2. Non-viral gene delivery technologies market: Mode Movement Analysis
4.3. Non-viral gene delivery technologies market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
4.4. Chemical
4.4.1. Chemical market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. LNPs
4.4.2.1. LNPs market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Polymers
4.4.3.1. Polymers market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Physical
4.5.1. Physical market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2. Electroporation
4.5.2.1. Electroporation market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Microinjection
4.5.3.1. Microinjection market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Application Segment Dashboard
5.2. Non-viral gene delivery technologies market Application Movement Analysis
5.3. Non-viral gene delivery technologies market Size & Trend Analysis, by mode, 2018 to 2030 (USD Million)
5.4. Research
5.4.1. Research market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Therapeutics
5.5.1. Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. Gene Therapy
5.5.2.1. Gene Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Cell Therapy
5.5.3.1. Cell Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. Vaccines
5.5.4.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Non-viral gene delivery technologies market End Use Movement Analysis
6.3. Non-viral gene delivery technologies market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Biotechnology and Biopharmaceutical Companies
6.4.1. Biotechnology and biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Research and academic institutes
6.5.1. Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis by mode, application, end use
7.1. Regional Dashboard
7.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
7.3. North America
7.3.1. North America Non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea Non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia Non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait non-viral gene delivery technologies market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. GenScript
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Danaher
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Rad Laboratories
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Altogen Biosystems
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Lonza
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Sonidel
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. SIRION BIOTECH GmbH
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Innovative Cell Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global non-viral gene delivery technologies market, by region, 2018 - 2030 (USD Million)
Table 3 Global non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 4 Global non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 5 Global non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 6 North America Non-viral gene delivery technologies market, by country, 2018 - 2030 (USD Million)
Table 7 North America Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 8 North America Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 9 North America Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 10 U.S. Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 11 U.S. Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 13 Canada Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 14 Canada Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 15 Canada Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 16 Mexico Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 17 Mexico Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 18 Mexico Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 19 Europe Non-viral gene delivery technologies market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 21 Europe Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 22 Europe Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 23 Germany Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 24 Germany Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 25 Germany Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 26 UK Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 27 UK Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 28 UK Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 29 France Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 30 France Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 31 France Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 32 Italy Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 33 Italy Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 34 Italy Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 35 Spain Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 36 Spain Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 37 Spain Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 38 Denmark Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 39 Denmark Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 40 Denmark Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 41 Sweden Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 42 Sweden Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 43 Sweden Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 44 Norway Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 45 Norway Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 46 Norway Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Non-viral gene delivery technologies market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 51 China Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 52 China Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 53 China Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 54 Japan Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 55 Japan Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 56 Japan Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 57 India Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 58 India Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 59 India Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 60 South Korea Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 61 South Korea Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 62 South Korea Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 63 Australia Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 64 Australia Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 65 Australia Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 66 Thailand Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 67 Thailand Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 68 Thailand Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America Non-viral gene delivery technologies market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 71 Latin America Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 72 Latin America Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 74 Brazil Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 75 Brazil Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 76 Argentina Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 77 Argentina Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 78 Argentina Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 79 Middel East & Africa Non-viral gene delivery technologies market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 83 South Africa Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 84 South Africa Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 85 South Africa Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 89 UAE Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 90 UAE Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 91 UAE Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
Table 92 Kuwait Non-viral gene delivery technologies market, by mode, 2018 - 2030 (USD Million)
Table 93 Kuwait Non-viral gene delivery technologies market, by end use, 2018 - 2030 (USD Million)
Table 94 Kuwait Non-viral gene delivery technologies market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Non-viral gene delivery technologies market: market outlook
Fig. 7 Laser capture microdissection competitive insights
Fig. 8 Parent market outlook
Fig. 9 Non-viral gene delivery technologies market driver impact
Fig. 10 Non-viral gene delivery technologies market restraint impact
Fig. 11 Non-viral gene delivery technologies market: Mode movement analysis
Fig. 12 Non-viral gene delivery technologies market: Mode outlook and key takeaways
Fig. 13 Chemical market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Physical market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 LNPs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Polymers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Electroporation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Microinjection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Non-viral gene delivery technologies market: Application movement analysis
Fig. 22 Non-viral gene delivery technologies market: Application outlook and key takeaways
Fig. 23 Research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Gene Therapy market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Cell Therapy market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 27 Vaccines market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 28 Non-viral gene delivery technologies market: End use movement analysis
Fig. 29 Non-viral gene delivery technologies market: End use outlook and key takeaways
Fig. 30 Biotechnology and biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 33 North America Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Canada non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Mexico non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Europe non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 UK non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Germany non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 France non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Denmark non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Sweden non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Norway non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 China non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Japan non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 India non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Thailand non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Korea Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Australia non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Latin America Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Brazil Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Argentina Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 South Africa Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 UAE Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Kuwait Non-viral gene delivery technologies market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • GenScript
  • Danaher
  • Merck KGaA
  • Bio-Rad Laboratories
  • Altogen Biosystems
  • Lonza
  • Sonidel
  • SIRION BIOTECH GmbH
  • Innovative Cell Technologies, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Gene Delivery Technologies Market by Type, Application, End User, Disease Indication - Global Forecast 2025-2030 - Product Image

Gene Delivery Technologies Market by Type, Application, End User, Disease Indication - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Gene Delivery Systems - Global Strategic Business Report - Product Image

Gene Delivery Systems - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Drug & Gene Delivery Devices Market by Route of Administration, Method, Vector - Global Forecast 2025-2030 - Product Image

Drug & Gene Delivery Devices Market by Route of Administration, Method, Vector - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.